Accuzyme® papain-urea debriding ointment: A historical review

Wounds

Volumn 15, Issue 4 SUPPL., 2003, Pages

  Wright, J Barry ^a   Shi, Lei ^b  

^a Healthpoint Ltd   (United States)

^b DPT Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCUZYME; ALCOHOL; BROMELAIN; CHYMOTRYPSIN; COLLAGENASE; DEOXYRIBONUCLEASE; DETERGENT; EUSOL; FICIN; FORMALDEHYDE; GENTAMICIN; HYDROGEN PEROXIDE; METALLOPROTEINASE; PAPAIN; PENICILLIN G; PLASMIN; PROTEINASE; SULFADIAZINE SILVER; TRYPSIN; UNCLASSIFIED DRUG; UREA DERIVATIVE; VIBRIOLYSIN;

AUTOLYSIS; BURN; DEBRIDEMENT; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG UTILIZATION; ENZYME DENATURATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME SPECIFICITY; FLY; HUMAN; HYDROLYSIS; OINTMENT; PHAGOCYTE; REVIEW; SKIN ULCER; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; WOUND CARE; WOUND DRESSING; WOUND HEALING;

EID: 0037884694     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Winter GD. Formation of the scab and the rate or epithelialization of superficial wounds in the skin of the young domestic pig. Nature 1962;193:293-4.
2. Yager DR, Zhang L-Y, Liang H-X, et al. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996;107:743-8.
3. Yager DR, Nwomeh BC. The proteolytic environment of chronic wounds. Wound Rep Regen 1999;7:433-41.
4. Di Colandrea T, Wang L, Wille J, et al. Epidermal expression of collagenase delays wound healing in transgenic mice. J Invest Dermatol 1998;111:1029-33.
5. Witte MB, Thornton FJ, Kiyama T, et al. Matrix metalloproteinase inhibitors and wound healing: A novel enhancer of wound strength. Surgery 1998:124:464-70.
6. Wright JB, Lam K, Buret AG, et al. Early healing events in a porcine model of contaminated wounds: Impact of nanocrystalline silver on matrix metalloproteinases, cellular apoptosis and wound healing. Wound Rep Regen 2002;10:141-51.
7. Demling RH, DeBiasse MA. Micronutrients in critical illness. Crit Care Clin 1995;11:651-73.
8. Demling RH, DiSanti L. Involuntary weight loss and the nonhealing wound: The role of anabolic agents. Adv Wound Care 1999;12(1 Suppl):1-14.
9. Clark RAF. Cutaneous tissue repair: Basic biologic considerations. I. J Am Acad Dermatol 1985;13:701-25.
10. Hellgren L, Vincent J. Debridement: An essential step in wound healing. In: Westerhoff W (ed). Leg Ulcers: Diagnosis and Treatment. Amsterdam, Netherlands: Elsevier Science, 1993;305.
11. Fowler E, van Rijswijk L. Using wound debridement to help achieve the goals of care. Ost/Wound Manag 1995;41:23S-35S.
12. Berger MM. Enzyme debriding preparations. Ost/Wound Manag 1993;39:61-9.
13. Fowler E. Instrument/sharp debridement of non-viable tissue in wounds. Ost/Wound Manag 1992;38:26-33.
14. Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg 1996;183:61-4.
15. Kerstein MD. Moist wound healing: The clinical perspective. Ost/Wound Manag 1995;41:37S-44S.
16. King N. Using synthetic autolytic debriding agents for the treatment of full-thickness dermal ulcers. In: Krasner D (ed). Chronic Wound Care: A Clinical Source Book for Healthcare Professionals. King of Prussia, PA: Health Management Publications, 1990;290.
17. Sibbald RG, Williamson D, Orsted HL, et al. Preparing the wound bed: Debridement, bacterial balance, and moisture balance. Ost/Wound Manag 2000;46:14-35.
18. Brennan SS, Leaper DJ. The effect of antiseptics on the healing wound: A study using the rabbit ear chamber. Br J Surg 1985;72:780-2.
19. Bolton L, Fattu AJ. Topical agents and wound healing. Clin Dermatol 1994;12:95-20.
20. Dolynchuk KN. Debridement. In: Krasner D, Rodeheaver GT, Sibbald RG (eds). Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, Third Edition. Wayne, PA: HMP Communications, 2001;385-90.
21. Rodeheaver GT. Wound cleansing, wound irrigation, wound disinfection. In: Krasner D, Rodeheaver GT, Sibbald RG (eds). Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, Third Edition. Wayne, PA: HMP Communications, 2001;369-83.
22. Tredget EE, Shankowsky HA, Joffe AM, et al. Epidemiology of infections with Pseudomonas aeruginosa in human patients: The role of hydrotherapy. Clin Infect Dis 1994;15:941-9.
23. Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Rep Regen 2002;10:208-14.
24. Vistnes LM, Lee R, Ksander GA. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery 1986;90:835-41.
25. Westerhof W, Jansen FC, de Wit FS, Cormane RH. Controlled double-blind trial of fibrinolysin-desoxyribonuclease (Elase) solution in patients with chronic leg ulcers who are treated before autologous skin grafting. J Am Acad Dermatol 1987;17:32-9.
26. Falabella AF, Carson P, Eaglstein WH, Falanga V. The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol 1998;39:737-40.
27. Durham DR, Fortney DZ, Nanney LB. Preliminary evaluation of vibriolysin, a novel proteolytic enzyme composition suitable for the debridement of burn wound eschar. J Burn Care Rehabil 1993;14:544-51.
28. Hebda PA, Flynn KJ, Dohar JE. Evaluation of the efficacy of enzymatic debriding agents for removal of necrotic tissue and promotion of healing in porcine skin wounds. WOUNDS 1998;10(3):83-96.
29. Shi L, Anguiano M, Wright JB, Shroot B. A novel method to assess efficacy of enzymatic wound debriding agents. Abstract. Miami Beach, FL: Annual Meeting of International Investative Dermatology, 2003.
30. Thomas AM, Harding KG, Moore K. The structure and composition of chronic wound eschar. J Wound Care 1999;8:285-7.
31. Kauzmann W. Factors in interpretation of protein denaturation. Adv Protein Chem 1959;14:1-63.
32. Miller JM, Howard F. The interaction of papain, urea, and water-soluble chlorophyll in a proteolytic ointment for infected wounds. Surgery 1957;43:939-48.
33. Sluyterman LAE. The effect of methanol, urea, and other solutes on the action of papain. Biochim Biophys Acta 1967;139:418-28.
34. Wurtz A, Bouchut E. Sur le ferment digestif du Carica papaya. Soc Biol 1879;89:425-8.
35. Modder EE. On the medicinal uses of Carica papaya L. Ceylon Med J 1887:115-9. As quoted by Burke and Golden, c.f. ref. 40.
36. Kilmer FB. The story of the papain. Am J Pharm 1901;73:272-85.
37. Glasser ST. A new treatment for sloughing wounds. Am J Surg 1940;50:320
38. Carter CH. Chronic ulcers. Medical Times 1958;86:1382.
39. Morrison JE, Casali JL. Continuous proteolytic therapy for decubitus ulcers. Am J Surg 1957;93:446.
40. Burke JF, Golden T. A clinical evaluation of enzymatic debridement with papin-urea-chlorophyllin ointment. Am J Surg 1958;95:828-42.
41. Alvarez OM, Fernandez-Obregon A, Rogers RS, et al. A prospective, randomized, comparative study of collagenase and papain-urea for pressure ulcer debridement. WOUNDS 2002;14(8):293-301.
42. Cooper GR, Hodge GB, Beard DW. Enzymatic debridement in local treatment of burns: A preliminary report. Am J Dis Child 1943;65:909.
43. Guzman AV, Guzman MGS. The enzymatic debridement of suppurations, necrotic lesions and burns with papain. J Internat Coll Surg 1953;20:695.
44. Final report and study data available from Healthpoint, Ltd., Ft. Worth, TX, upon written request.